A pharmacokinetic/pharmacodynamic study comparing arformoterol tartrate inhalation solution and racemic formoterol dry powder inhaler in subjects with chronic obstructive pulmonary... by Kharidia, J, Fogarty, C.M, LaForce, C.F, Maier, G, Hsu, R, Dunnington, K.M, Curry, L, Baumgartner, R.A, Hanrahan, J.P

Get full text

Patient Comparison of Sensory Attributes of Olopatadine and Azelastine Nasal Sprays by Meltzer, E.O, Berger, W.E, Chadwick, S.J, Gross, G, LaForce, C.F, Garadi, R, Crenshaw, K, Wall, G.M

Get full text

Ciclesonide, a novel inhaled steroid, has no effect on hypothalamic-pituitary-adrenal (HPA)-axis function in mild-to-moderate asthmatics by LaForce, C.F., Baker, J.W., Amin, D., Rohatagi, S., Mendes, P., Williams, J., Kundu, S., Banerji, D.

Get full text

INS37217 intranasal, a P2Y2 receptor agonist, is a novel treatment for allergic rhinitis by Schaberg, A.E., Meltzer, E.O., LaForce, C.F., Pearlman, D.S., Ice, J.C., LaVange, L.M., Kellerman, D.J.

Get full text

618 Symptom relief from an acute episode of recurring sinusitis with fluticasone propionate aqueous nasal spray as adjunctive therapy to cefuroxime axetil by LaForce, C.F, Settipane, G.A, Charous, B.L, Goode-Sellers, S.T, Westlund, R.E, Rickard, K.A, cook, C.K

Get full text

67 Recombinant human monoclonal anti-IgE therapy in allergic rhinitis by Casale, T.B., Bernstein, I.L., Busse, W.W., LaForce, C.F., Tinkelman, D.G., Stoltz, R.R., Dockhorn, R.J., Adelman, D.C.

Get full text